Pediatrik Kanser Hastalarında Oral Mukozit ve Ağız Sağlığı

Sitotoksik kemoterapi görecek veya kemoterapi almakta olan pediatrik kanser hastalarının ağız-diş sağlıklarının korunması, özel bir yaklaşım gerektirir. Pediatrik hastaların ağız-diş sağlığı, kemoterapinin sonuçlarını etkileyen önemli bir belirleyicidir. Pediatrik kanser hastalarında gelişen tüm septisemilerin üçte birinin oral enfeksiyonlara bağlı geliştiği bildirilmiştir 1,2 . Bu nedenle, kemoterapiden önce ağız dokularının muayenesinin ve gerekli tedavilerinin, kanser hastalarında bakım protokollerinin bir parçası olması gerektiği ifade edilmektedir 3 .

PDF

___

1. Bergmann OJ. Oral infections and septicemia in immunocomprimised patients with haemotoligical malignancies. JCM 1988; 10:2105-09.
2. Bergmann OJ. Oral infections and fever in immunocomprimised patients with haemotoligical malignancies. Eur J Clin Infec Dis 1989; 3:207- 13.
3. Council on Clinical Affairs. Clinical guideline on the dental management of pediatric patients receiving chemotherapy, bone marrow transplantation and/or radiation. American Academy of Pediatric Dentistry 2001; 5:82-4.
4. Wilkes JD. Prevention and treatment of oral mucositis following cancer chemotherapy. Semin Oncol 1p998; 25:538-51.
5. Loprinzi CL, Gastineau DA, Foote RL. Oral complications. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, (eds). Clinical Oncology. Newyork, Churchill Livingstone; 1995. p.741-54.
6. Madeya ML. Oral complications from cancer therapy: part 1-pathophysiology and secondary complications. Oncol Nurs Forum 1996; 23:801- 17.
7. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998; 34:39-43.
8. Graham KM, Pecoraro DA, Ventura M, Meyer CC. Reducing the incidence of stomatitis using a quality assessment and improvement approach. Cancer Nurs 1993; 16:117-22.
9. Bethesda MD. Concensus development conference statement on oral complications of cancer therapies: diagnosis, prevention, and treatment. National Institutes of Health 1989; 4:1-12.
10. Dodd MJ, Larson PJ, Dibble SL, et al. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Fourm 1996; 23:921-7.
11. Donnely JP, Bellm LA, Epstein JB, et al. Antimicrobial therapy to prevent or treat oral mucositis. THE LANCET Infectious Diseases 2003; 3:405-12.
12. Leggott PJ. Oral complications in paediatric population. NCI Monographs 1990; 9:129-31.
13. Bonnaure-Mallet M, Bunetel L, Tricot-Doleux S, et al. Oral complications during treatment of malignant diseases in childhood: effects of tooth brushing. Eur J Cancer 1998; 34:1588-91.
14. Cheng KKF, Molassiotis A, Chang AM, et al. Evaulation of an oral care protocol intervention of chemotherapy-induced oral mucositis in paediatric cancer patients. Eur J Oncol Nursing 2001; 37:2056-63.
15. Childers NK, Stinnett EA, Wheeler P, et al. Oral complications in children with cancer. Oral Surg Oral Med Oral Pathol 1993; 75:41-7.
16. Berger AM, Kilroy TJ. Oral complications. In DeVita V.T, Hellman S, Rosenberg S.A, eds. Cancer: Principles and Practice of Oncology. Philedelphia, Lippincott-Raven Publishers. 1997. p.2714-25.
17. Dreizen S. Description and incidence of oral complications. NCI Monographs 1991; 9:11-5.
18. Sonis S, Clark J. Prevention and management of oral mucositis induced by antineoplastic therapy. Oncol 1991; 5:11-7.
19. Sonis A, Sonis S. Oral complications of cancer chemotherapy in pediatric patients. J Periodontol 1979; 3:122-8.
20. Schubert MM, Williams BE, Lloid ME, Donaldson G, Chapko M.K. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index. Cancer 1992; 69:2469-77.
21. Coda B.A, O’Suillivan B, Donaldson G, et al. Comparative efficacy of patients-controlled administration of morphine, hydromorphine, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain 1997; 72:333-46.
22. Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J, et al. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Infec Dis 1996; 15:291-6.
23. Eting LS, Bodey GP, Keefe B.H. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 1992; 14:1201-7.
24. Biron P, Sebban C, Gourmet R, et al. Research controversies in management of oral mucositis. Support Care Cancer 2000; 8:68-71.
25. Cheng KKF, Molassiotis A, Chang AM. An oral care protocol intervention to prevent chemotherapy-induced oral mucositis in paediatric cancer patients: a pilot study. Eur J Oncol Nursing 2002; 6:66-73.
26. Raber-Durlacher JE. Current Practices for management of oral mucositis in cancer patients. Support Care Cancer 1999; 7:71-4.
27. Epstein JB, Vickars L, Spinelli J, Reece D. Efficacy of chlohexidine and nystatine rinses in prevention of oral complications in leukemia and bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1989; 73:682-9.
28. Seto BG, Kim M, Wolinsky L, et al. Oral mucositis in patients undergoing bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1985; 60:493-7.